Sopharma AD notifies that on 8 December 2017 the Company received two notifications from Rompharm Company OOD for the sale of shares from the capital of Sopharma AD.

The first notification concerns the sale of 6 000 000 shares, as a result of which the share of Rompharm Company OOD in the capital of Sopharma AD fell under 15% to 12.88%. The date of the registration of the transaction with the Central Depository is 7 December 2017.

Sopharma AD hereby informs that on 7 December 2017 the Company bought 105 844 own shares representing 0.0785%  of the share capital of the Company, at a total value of 451 979.92 BGN on the Bulgarian Stock Exchange, the average price per share was 4.27 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

Sopharma AD hereby informs that on 6 December 2017 the Company bought 2 691 292 own shares representing 1.997% of the share capital of the Company, at a total value of 11 491 816.84  BGN on the Bulgarian Stock Exchange, the average price per share was 4.27 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

Sopharma AD hereby informs that on 6 December 2017 the Company bought 3 061 292 own shares representing 2.271% of the share capital of the Company, at a total value of 13 071 716.84 BGN on the Bulgarian Stock Exchange, the average price per share was 4.27 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.